154 related articles for article (PubMed ID: 35363249)
21. Contribution of interferon gamma release assays testing to the diagnosis of latent tuberculosis infection in HIV-infected patients: a comparison of QuantiFERON-TB Gold In Tube, T-SPOT.TB and tuberculin skin test.
Ramos JM; Robledano C; Masiá M; Belda S; Padilla S; Rodríguez JC; Gutierrez F
BMC Infect Dis; 2012 Jul; 12():169. PubMed ID: 22849726
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
23. Interferon gamma release assay tests are associated with persistence and completion of latent tuberculosis infection treatment in the United States: Evidence from commercial insurance data.
Stockbridge EL; Loethen AD; Annan E; Miller TL
PLoS One; 2020; 15(12):e0243102. PubMed ID: 33270737
[TBL] [Abstract][Full Text] [Related]
24. Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States.
Zavala S; Winglee K; Ho CS; Pettit AC; Ahmed A; Katz DJ; Belknap RW; Stout JE
Ann Am Thorac Soc; 2023 Sep; 20(9):1258-1266. PubMed ID: 37159954
[No Abstract] [Full Text] [Related]
25. Trends in diagnostic methods and treatment of latent tuberculosis infection in a tertiary care center from 2000 to 2017.
Uzorka JW; Duinkerk DL; Kroft LJM; Bakker JA; Ramai RSRS; Ottenhoff THM; Arend SM
Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1329-1337. PubMed ID: 32076881
[TBL] [Abstract][Full Text] [Related]
26. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
[TBL] [Abstract][Full Text] [Related]
27. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
[TBL] [Abstract][Full Text] [Related]
29. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN- γ release assay and IFN-γ-induced protein-10.
Ghanaie RM; Karimi A; Azimi L; James S; Nasehi M; Mishkar AP; Sheikhi M; Fallah F; Tabatabaei SR; Hoseini-Alfatemi SM
BMC Pediatr; 2021 Feb; 21(1):76. PubMed ID: 33573613
[TBL] [Abstract][Full Text] [Related]
32. A prospective cohort study of latent tuberculosis in adult close contacts of active pulmonary tuberculosis patients in Korea.
Park SH; Lee SJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Kim HJ; Menzies D
Korean J Intern Med; 2016 May; 31(3):517-24. PubMed ID: 27052266
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Latent Tuberculosis Infection Among Non-US-Born Persons by Country of Birth-United States, 2012-2017.
Collins JM; Stout JE; Ayers T; Hill AN; Katz DJ; Ho CS; Blumberg HM; Winglee K;
Clin Infect Dis; 2021 Nov; 73(9):e3468-e3475. PubMed ID: 33137172
[TBL] [Abstract][Full Text] [Related]
34. A cross-sectional study of latent tuberculosis infection, insurance coverage, and usual sources of health care among non-US-born persons in the United States.
Annan E; Stockbridge EL; Katz D; Mun EY; Miller TL
Medicine (Baltimore); 2021 Feb; 100(7):e24838. PubMed ID: 33607853
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
36. Positive rate and risk factors of latent tuberculosis infection among persons living with HIV in Jiangsu Province, China.
Zhang Y; Lu P; Wu K; Zhou H; Yu H; Yuan J; Dong L; Liu Q; Lu W; Yang H; Cao D; Zhu L
Front Cell Infect Microbiol; 2023; 13():1051060. PubMed ID: 36960041
[TBL] [Abstract][Full Text] [Related]
37. Lessons Learned from Implementation of an Interferon Gamma Release Assay to Screen for Latent Tuberculosis Infection in a Large Multicenter Observational Cohort Study in Brazil.
Costa AG; Carvalho BKS; Araújo-Pereira M; Ibiapina HNS; Spener-Gomes R; Souza AB; Gomes-Silva A; Andrade AMS; Silva EC; Arriaga MB; Benjamin A; Rocha MS; Moreira ASR; Oliveira JG; Figueiredo MC; Turner MM; Durovni B; Cavalcante S; Kritski AL; Rolla VC; Sterling TR; Andrade BB; Cordeiro-Santos M;
Microbiol Spectr; 2021 Dec; 9(3):e0116321. PubMed ID: 34851140
[TBL] [Abstract][Full Text] [Related]
38. Outcomes of latent tuberculosis infection treatment in Istanbul.
Güner AE; Kiziltas S; Babalik A; Sahin E; Sibel A; Safak M; Kiliçaslan Z
Int J Mycobacteriol; 2022; 11(4):442-447. PubMed ID: 36510932
[TBL] [Abstract][Full Text] [Related]
39. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
El-Helaly M; Khan W; El-Saed A; Balkhy HH
J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
[TBL] [Abstract][Full Text] [Related]
40. [Prevalence of latent infection with Mycobacterium tuberculosis in Mazovia Region using interferon gamma release assay after stimulation with specific antigens ESAT-6 and CFP-10].
Kuś J; Demkow U; Lewandowska K; Korzeniewska-Koseła M; Rabczenko D; Siemion-Szcześniak I; Białas-Chromiec B; Bychawska M; Sapigórski P; Maciejewski J
Pneumonol Alergol Pol; 2011; 79(6):407-18. PubMed ID: 22028119
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
